A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma
J. Gains, V. V. Moroz, Matthew Aldridge, Simon Wan, Keith Wheatley, Jennifer Laidler, Connie Peet, Jamshed Bomanji, Mark N. Gaze
Topics & Concepts
MedicineNeuroblastomaRefractory (planetary science)Radiation therapyToxicityClinical trialStage (stratigraphy)Internal medicineConfidence intervalOncologyChemotherapySurgeryUrologyPaleontologyGeneticsAstrobiologyPhysicsBiologyCell cultureNeuroblastoma Research and TreatmentsCancer, Hypoxia, and MetabolismNeuroendocrine Tumor Research Advances